Clinical Trial Update: Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting efficacy and safety data for a pregabalin sustained release tablet in postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin sustained release tablet (pregabalin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Postherpetic Neuralgia | Phase 3 | Status: UNKNOWN